The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Coexpression of HER3 as a predictor of survival in HER2-positve breast cancer patients.
Rupert Bartsch
Research Funding - Roche
Anna Sophie Berghoff
No relevant relationships to disclose
Zsuzsanna Bago-Horvath
No relevant relationships to disclose
Matthias Preusser
No relevant relationships to disclose
Guenther G. Steger
No relevant relationships to disclose
Margareta Rudas
No relevant relationships to disclose
Peter Birner
No relevant relationships to disclose
Christoph Zielinski
No relevant relationships to disclose